(4R,4aR,5S,6S,7S)-4-氟-六氢-5,6-二羟基-7-(羟基甲基)吡咯并[1,2-c][1,3]恶嗪-1-酮, (4R,4aR,5S,6S,7S)-4-Fluoro-hexahydro-5,6-dihydroxy-7-(hydroxymethyl)pyrrolo[1,2-c][1,3]oxazin-1-one

(1R,2R,3R,7AS)-7,7-二氟-六氢-3-(羟甲基)-1H-吡咯-1,2-二醇, (1R,2R,3R,7aS)-7,7-difluoro-hexahydro-3-(hydroxymethyl)-1H-pyrrolizine-1,2-diol

2,3,5-三-O-苄基-4-O-甲磺酰基-D-核糖, 2,3,5-Tri-O-benzyl-4-O-methylsulfonyl-D-ribose

(1S,2R,3R,4S,5R)-5-(苄基氨基)环庚烷-1,2,3,4-四醇, (1S,2R,3R,4S,5R)-5-(Benzylamino)cycloheptane-1,2,3,4-tetraol

(1S,5S,6S,7S,7aS)-5-((S)-1,2-双(苄氧基)乙基)-7-(苄氧基)-6-氟-四氢-1-(羟基甲基)吡咯并[1,2,2-C]唑-3(1H)-酮, (1S,5S,6S,7S,7aS)-5-((S)-1,2-Bis(benzyloxy)ethyl)-7-(benzyloxy)-6-fluoro-tetrahydro-1-(hydroxymethyl)pyrrolo[1,2-c]oxazol-3(1H)-one

(3S,4R,5R)-哌啶-3,4,5-三醇, (3S,4R,5R)-Piperidine-3,4,5-triol

(3R,5R)-1-壬基哌啶-3,4,5-三醇, (3R,5R)-1-Nonylpiperidine-3,4,5-triol

2,3,5-三-O-苄基-D-木糖, 2,3,5-Tri-O-benzyl-D-xylose

1,2:5,6-二-O-异亚丙基-3-O-咪唑基磺酰基-α-D-阿洛-呋喃戊糖, 1,2:5,6-Di-O-isopropylidene-3-O-imidazolyl sulfonyl-α-D-allo-pentofuranose

HTPQA, 5.0 mM in DMSO solution